Company page
Design Therapeutics, Inc.
Design Therapeutics, Inc. is a public company traded under the ticker DSGN in the American market. With a market capitalization of approximately $685 million, the company focuses on developing innovative therapies for genetic diseases. Design Therapeutics aims to address unmet medical needs through its proprietary technology and research initiatives.
- Ticker
- DSGN:NASDAQ
- Asset type
- Stock
- Market cap
- $685.2M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD